Market Research Logo

Global Atopic Dermatitis Market Report: 2016 Edition

Global Atopic Dermatitis Market Report: 2016 Edition

Atopic dermatitis (AD) is a chronic, inflammatory skin disease of unknown origin that usually starts in early infancy, but also affects a substantial number of adults. Atopic dermatitis is a long lasting skin disease that affects a large percentage of the world's population and is a special type of hypersensitivity that is associated with asthma, inhalant allergies (hay fever), and a chronic dermatitis. The symptoms of atopic dermatitis are itching, red to brownish grey patches and small raised bumps.

The main cause of atopic dermatitis is unknown but it is assumed to be caused due to genetics, dry skin and environmental conditions. Multiple factors can trigger or worsen atopic dermatitis, including low humidity, seasonal allergies, exposure to harsh soaps and detergents, and cold weather. There has been no specified biologic till now for atopic dermatitis. But recent efforts by many companies have shown positive results and the first biologic may get launched in 2017. After that many other products are still in pipeline.

The key factors which are anticipated to drive atopic dermatitis market include increase in global population, improvement in the global health care expenditure, accelerated economic growth, pollution and climatic factors and role of triggers. Some of the significant developments of this industry include introduction of new biologics, biomarker in atopic dermatitis and opportunity for new entrants. However, the challenge to be faced ahead is time to be taken in drug adoption, high price and legal regulations.

This report offers a comprehensive analysis of the atopic dermatitis market. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global market is reined by few major players namely Sanofi, Glaxo Smithkline (GSK), AstraZeneca and Roche Holding. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.


1. Atopic Dermatitis: An Introduction
1.1 Symptoms of Atopic Dermatitis
1.2 Causes of Atopic Dermatitis
1.3 Factors which worsen Atopic Dermatitis
1.4 Different Types of Eczema
1.5 Skin Features of Atopic Dermatitis
1.6 Stages of Atopic Dermatitis
1.7 Prevention of Atopic Dermatitis
1.8 Treatment of Atopic Dermatitis
Table 1: Atopic Dermatitis Treatment Algorithm
2. Atopic Dermatitis – Global Market
2.1 Global Atopic Dermatitis Treatment Market by Value
Table 2: Global Atopic Dermatitis Treatment Forecast by Value (2017E-2025E)
2.2 Global Adults Affected with Atopic Dermatitis
Table 3: Global Adults Affected with Atopic Dermatitis (2015-2025E)
2.3 Global Adults Diagnosed with Atopic Dermatitis
Table 4: Global Adults Diagnosed with Atopic Dermatitis (2015-2025E)
2.4 Global Adults with Moderate to Severe Atopic Dermatitis
Table 5: Global Adults with Moderate to Severe Atopic Dermatitis (2015-2025E)
2.5 Global Adults Refractory to Topical Therapies
Table 6: Global Adults from Adult Refractory to Topical Therapies (2015-2025E)
3. Atopic Dermatitis - Regional Markets
3.1 The US Atopic Dermatitis Market
3.1.1 The US Atopic Dermatitis Treatment Market by Value
Table 7: The US Atopic Dermatitis Treatment Forecast by Value (2017E-2025E)
3.1.2 The US Adults Affected with Atopic Dermatitis
Table 8: The US Adults Affected with Atopic Dermatitis (2015-2025E)
3.1.3 The US Adults Diagnosed with Atopic Dermatitis
Table 9: The US Adults Diagnosed with Atopic Dermatitis (2015-2025E)
3.1.4 The US Adults with Moderate to Severe Atopic Dermatitis
Table 10: The US Adult with Moderate to Severe Atopic Dermatitis (2015-2025E)
3.1.5 The US Adults Refractory to Topical Therapies by Volume
Table 11: The US Adult Refractory to Topical Therapies (2015-2025E)
3.1.6 The US Treated Patients by Volume
Table 12: The US Treated Patients by Volume (2017E-2025E)
3.1.7 Severity Level for Atopic Dermatitis Patients for Different Age Groups
Table 13: Severity Level for Atopic Dermatitis Patients for less than 5 years (2015)
Table 14: Severity Level for Atopic Dermatitis Patients for 5 – 18 years (2015)
Table 15: Severity Level for Atopic Dermatitis Patients for Greater than 18 years (2015)
Table 16: Time Duration of Infection (2015)
Table 17: Market Share of People Receiving Treatment (2015)
Table A: Treatments Received by Patients
3.2 European Union Atopic Dermatitis Market
3.2.1 EU Atopic Dermatitis Treatment Market by Value
Table 18: EU Atopic Dermatitis Treatment Forecast by Value (2018E-2025E)
3.2.2 EU Adults Affected with Atopic Dermatitis
Table 19: EU Adults Affected with Atopic Dermatitis (2015-2025E)
3.2.3 EU Adults Diagnosed with Atopic Dermatitis
Table 20: EU Adults Diagnosed with Atopic Dermatitis (2015-2025E)
3.2.4 EU Adults with Moderate to Severe Atopic Dermatitis
Table 21: EU Adults with Moderate to Severe Atopic Dermatitis (2015-2025E)
3.2.5 EU Adult Refractory to Topical Therapies by Volume
Table 22: EU Adult Refractory to Topical Therapies (2015-2025E)
3.2.6 EU Treated Patients by Volume
Table 23: EU Treated Patients by Volume (2018E-2025E)
3.3 ROW Atopic Dermatitis Market
3.3.1 ROW Atopic Dermatitis Treatment Market by Value
Table 24: ROW Atopic Dermatitis Treatment Forecast by Value (2017E-2025E)
3.3.2 ROW Adults with Moderate to Severe Atopic Dermatitis
Table 25: ROW Adults with Moderate to Severe Atopic Dermatitis (2015-2025E)
3.3.3 ROW Adults Refractory to Topical Therapies by Volume
Table 26: ROW Adults Refractory to Topical Therapies (2015-2025E)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increase in Global Population
Table 27: Global Population (2006-2015)
4.1.2 Increase in Health Care Expenditure
Table 28: Global Health Care Expenditure (2007-2015E)
4.1.3 Accelerated Economic Growth
Table 29: Improving Global GDP (2007-2015E)
4.1.4 Pollution and Climate Factors
Table 30: Global Urban Population (2007-2015E)
4.1.5 Role of Triggers
4.2 Trends and Development
4.2.1 Introduction of New Biologics
4.2.2 Biomarker in Atopic Dermatitis
4.2.3 Opportunity for New Entrants
4.3 Challenges
4.3.1 Drug Adoption Takes Time
4.3.2 High Price
4.3.3 Legal Regulations
5. Competitive Landscape
5.1 Pipeline Biologics for Atopic Dermatitis Treatment
Table B: Pipeline Biologics for Atopic Dermatitis Treatment
5.2 Key Product Analysis
5.2.1 Dupilumab
Table 31: Global Dupilumab Market by Value (2017E-2025E)
Table 32: The US Dupilumab Market by Value (2017E-2025E)
Table 33: European Union Dupilumab Market by Value (2018E-2025E)
5.2.2 Nemolizumab
Table 34: Global Nemolizumab Market by Value (2019E-2025E)
Table 35: The US Nemolizumab Market by Value (2019E-2025E)
Table 36: European Union Nemolizumab Market by Value (2020E-2025E)
5.2.3 Lebrikizumab
Table 37: Global Lebrikizumab Market by Value (2019E-2025E)
Table 38: The US Lebrikizumab Market by Value (2019E-2025E)
Table 39: European Union Lebrikizumab Market by Value (2020E-2025E)
5.2.4 Tralokinumab
Table 40: Global Tralokinumab Market by Value (2019E-2025E)
Table 41: The US Tralokinumab Market by Value (2019E-2025E)
Table 42: European Union Tralokinumab Market by Value (2020E-2025E)
6. Company Profiles
6.1 Sanofi
6.1.1 Business Overview
Table 43: Sanofi’s Revenue Share by Segment (2015)
Table 44: Sanofi’s Revenue Share by Geography (2015)
6.1.2 Financial Overview
Table 45: Sanofi’s Revenue and Net Income (2011-2015)
6.1.3 Business Strategies
6.2 GSK
6.2.1 Business Overview
Table 46: GSK’s Revenue Share by Segment (2015)
Table 47: GSK’s Revenue Share by Geography (2015)
6.2.2 Financial Overview
Table 48: GSK’s Revenue and Net Income (2011-2015)
6.2.3 Business Strategies
6.3 AstraZeneca
6.3.1 Business Overview
Table 49: AstraZeneca’s Revenue Share by Segment (2015)
Table 50: AstraZeneca’s Revenue Share by Geography (2015)
6.3.2 Financial Overview
Table 51: AstraZeneca’s Revenue and Net Income (2011-2015)
6.3.3 Business Strategies
6.4 Roche Holding
6.4.1 Business Overview
Table 52: Roche’s Revenue Share by Segment (2015)
6.4.2 Financial Overview
Table 53: Roche’s Sales and Net Income (2011-2015)
6.4.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report